You have no items in your shopping cart.

simulation page

Risk Analysis for Merck and Company: Product KL-798
Bodily, Samuel E.; Faulk, John
Share This Product
Risk Analysis for Merck and Company: Product KL-798
Bodily, Samuel E.; Faulk, John Case QA-0600 / Published September 25, 2002 / 4 pages.
Format Price Quantity Select
This product is sold out

Product Overview

This case builds on the case "Merck & Company: Product KL-798" (UVA-QA-0582) by providing market uncertainties for the drug (drug quality, the presence of a competitor, market growth, and the time to the drug's release). Student and faculty spreadsheets are provided for the calculation of net present values for the scenarios. There is an additional challenge of how to treat the several downstream decisions (using OptQuest, for example) and how to value the license opportunity. A teaching note is also available to registered faculty members.




Select Format
Choose your delivery format to add this product to your cart or save it to your library. Please allow 10 minutes after purchasing for delivery of your electronic materials.
  • Videos List

  • Overview

    This case builds on the case "Merck & Company: Product KL-798" (UVA-QA-0582) by providing market uncertainties for the drug (drug quality, the presence of a competitor, market growth, and the time to the drug's release). Student and faculty spreadsheets are provided for the calculation of net present values for the scenarios. There is an additional challenge of how to treat the several downstream decisions (using OptQuest, for example) and how to value the license opportunity. A teaching note is also available to registered faculty members.

  • Learning Objectives